About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Huawei said group R&D investment in 1H 2026 was 121.4 bln yuan, a record for the period; R&D expense ratio was 25.9%. R&D outlays rose 25.2% YoY. Full-year 2025 R&D investment was 192.3 bln yuan with a 21.8% expense ratio. Cumulative R&D investment o

2026-10-12

Huawei said group R&D investment in 1H 2026 was 121.4 bln yuan, a record for the period; R&D expense ratio was 25.9%. R&D outlays rose 25.2% YoY. Full-year 2025 R&D investment was 192.3 bln yuan with a 21.8% expense ratio. Cumulative R&D investment over the past decade reached 1.382 tln yuan, and Huawei said its global R&D ranking has been in the top six for nine consecutive years.

Other News
2026-10-11

BP: As weather conditions improve, the company is arranging for personnel to return and working to safely restart production at the Na Kika and Thunder Horse platforms in the Gulf of Mexico.

BP: As weather conditions improve, the company is arranging for personnel to return and working to safely restart production at the Na Kika and Thunder Horse platforms in the Gulf of Mexico.
2026-10-11

CITIC Securities says investor focus will shift to US Q3 earnings after US equities showed some rate-decoupling over the domestic holiday. LSEG consensus shows S&P 500 Q3 2026 revenue and EPS YoY growth of 1.2% and 45.0%, respectively, with QoQ moder

CITIC Securities says investor focus will shift to US Q3 earnings after US equities showed some rate-decoupling over the domestic holiday. LSEG consensus shows S&P 500 Q3 2026 revenue and EPS YoY growth of 1.2% and 45.0%, respectively, with QoQ moderation. At the industry level, energy, information technology, materials and healthcare all report YoY earnings growth above 50% — indicating high earnings growth is no longer confined to leading tech names and that non-tech contributions are rising materially. For Hong Kong stocks, higher global rates plus renewed AI trading have kept liquidity under pressure, but fundamentals appear to have bottomed and earnings-growth forecasts for major broad indices are being revised up. Earnings revisions are highly divergent by sector: some niche segments are being upgraded while domestic-demand exposed sectors still face downward revisions. Q3 results will be the key test of any recovery. CITIC recommends patient positioning in Hong Kong equities and expectations short-term dividend-focused strategies to relatively outperform.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.